These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 30726167)

  • 1. Substance Use Stigma, Primary Care, and the New York State Prescription Drug Monitoring Program.
    Allen B; Harocopos A; Chernick R
    Behav Med; 2020; 46(1):52-62. PubMed ID: 30726167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary care provider perspectives on and utilization of a mandatory prescription drug monitoring program in New York City.
    Harocopos A; Allen B; Chernick R
    Fam Pract; 2022 Mar; 39(2):264-268. PubMed ID: 34268573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary Care Implementation of a Mandatory Prescription Drug Monitoring Program in New York City.
    Chernick R; Allen B; Harocopos A
    J Behav Health Serv Res; 2022 Apr; 49(2):122-133. PubMed ID: 34426933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utilization of prescription drug monitoring programs for prescribing and dispensing decisions: Results from a multi-site qualitative study.
    Freeman PR; Curran GM; Drummond KL; Martin BC; Teeter BS; Bradley K; Schoenberg N; Edlund MJ
    Res Social Adm Pharm; 2019 Jun; 15(6):754-760. PubMed ID: 30243575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A survey of Physicians' Perspectives on the New York State Mandatory Prescription Monitoring Program (ISTOP).
    Blum CJ; Nelson LS; Hoffman RS
    J Subst Abuse Treat; 2016 Nov; 70():35-43. PubMed ID: 27692186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A typology of prescription drug monitoring programs: a latent transition analysis of the evolution of programs from 1999 to 2016.
    Smith N; Martins SS; Kim J; Rivera-Aguirre A; Fink DS; Castillo-Carniglia A; Henry SG; Mooney SJ; Marshall BDL; Davis C; Cerdá M
    Addiction; 2019 Feb; 114(2):248-258. PubMed ID: 30207015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trends in Florida's Prescription Drug Monitoring Program registration and utilization: Implications for increasing voluntary use.
    Delcher C; Wang Y; Young HW; Goldberger BA; Schmidt S; Reisfield GM
    J Opioid Manag; 2017; 13(5):283-289. PubMed ID: 29199394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Effect of a Statewide Mandatory Prescription Drug Monitoring Program on Opioid Prescribing by Emergency Medicine Providers Across 15 Hospitals in a Single Health System.
    Suffoletto B; Lynch M; Pacella CB; Yealy DM; Callaway CW
    J Pain; 2018 Apr; 19(4):430-438. PubMed ID: 29241835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. State-level prescription drug monitoring program mandates and adolescent injection drug use in the United States, 1995-2017: A difference-in-differences analysis.
    Earlywine JJ; Hadland SE; Raifman J
    PLoS Med; 2020 Sep; 17(9):e1003272. PubMed ID: 32976539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characteristics of state prescription drug monitoring programs: a state-by-state survey.
    Manasco AT; Griggs C; Leeds R; Langlois BK; Breaud AH; Mitchell PM; Weiner SG
    Pharmacoepidemiol Drug Saf; 2016 Jul; 25(7):847-51. PubMed ID: 27061342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluating Emergency Department Opioid Prescribing Behaviors After Education About Mandated Use of the Pennsylvania Prescription Drug Monitoring Program.
    Martello J; Cassidy B; Mitchell A
    J Addict Nurs; 2018; 29(3):196-202. PubMed ID: 30180006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physician attitudes and experiences with Maryland's prescription drug monitoring program (PDMP).
    Lin DH; Lucas E; Murimi IB; Jackson K; Baier M; Frattaroli S; Gielen AC; Moyo P; Simoni-Wastila L; Alexander GC
    Addiction; 2017 Feb; 112(2):311-319. PubMed ID: 27658522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of prescription drug monitoring programs (PDMPs) on opioid utilization among Medicare beneficiaries in 10 US States.
    Moyo P; Simoni-Wastila L; Griffin BA; Onukwugha E; Harrington D; Alexander GC; Palumbo F
    Addiction; 2017 Oct; 112(10):1784-1796. PubMed ID: 28498498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prescription drug monitoring program design and function: A qualitative analysis.
    Rutkow L; Smith KC; Lai AY; Vernick JS; Davis CS; Alexander GC
    Drug Alcohol Depend; 2017 Nov; 180():395-400. PubMed ID: 28978492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How, why, and for whom do emergency medicine providers use prescription drug monitoring programs?
    Smith RJ; Kilaru AS; Perrone J; Paciotti B; Barg FK; Gadsden SM; Meisel ZF
    Pain Med; 2015 Jun; 16(6):1122-31. PubMed ID: 25688454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Research to support optimization of prescription drug monitoring programs.
    Doyle S; Leichtling G; Hildebran C; Reilly C
    Pharmacoepidemiol Drug Saf; 2017 Nov; 26(11):1425-1427. PubMed ID: 28905438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Last State to Grant Nurse Practitioners DEA Licensure: An Education Improvement Initiative on the Florida Prescription Drug Monitoring Program.
    Kellams JR; Maye JP
    J Addict Nurs; 2017; 28(3):135-142. PubMed ID: 28863055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Associations between statewide prescription drug monitoring program (PDMP) requirement and physician patterns of prescribing opioid analgesics for patients with non-cancer chronic pain.
    Lin HC; Wang Z; Boyd C; Simoni-Wastila L; Buu A
    Addict Behav; 2018 Jan; 76():348-354. PubMed ID: 28898808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Past-year Prescription Drug Monitoring Program Opioid Prescriptions and Self-reported Opioid Use in an Emergency Department Population With Opioid Use Disorder.
    Hawk K; D'Onofrio G; Fiellin DA; Chawarski MC; O'Connor PG; Owens PH; Pantalon MV; Bernstein SL
    Acad Emerg Med; 2018 May; 25(5):508-516. PubMed ID: 29165853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advanced visualizations to interpret prescription drug monitoring program information.
    Weiner SG; Sherritt KM; Tseng Z; Tripathi J
    Drug Alcohol Depend; 2019 Aug; 201():260-265. PubMed ID: 31276986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.